Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- For women suffering from unexplained infertility, crushing fatigue, or resistant weight gain, hearing "your labs are normal" can feel like a dead end....
-
Vista, CA, March 18, 2026 (GLOBE NEWSWIRE) -- Mindera Health, a leader in precision medicine for dermatological conditions, and Mountaineer Biosciences today announced the launch of Subtilitas, a...
-
Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric...
-
Austin, United States, March 17, 2026 (GLOBE NEWSWIRE) -- Predictive Biomarkers Market Size & Growth Analysis: According to SNS Insider, The Predictive Biomarkers Market size is estimated at...
-
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update Phase 2 interim results suggest treatment with active immunotherapy ACI-7104 may slow the progression of Parkinson’s...
-
Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "AI in Precision Medicine Market, till 2040: Distribution by Type of Component, Type of Technology, Therapeutic Area and Key Geographical Regions:...
-
Grand Cayman, Cayman Island, March 05, 2026 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, reminds its...
-
Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "AI in Genomics Market, till 2040: Distribution by Type of Component, Type of Technology, Type of Functionality, Type of Application, Type of End User,...
-
Dublin, March 03, 2026 (GLOBE NEWSWIRE) -- The "Middle East DNA Synthesis Market, till 2035: Industry Trends and Forecasts - Distribution by Method of DNA, Key Application Areas and Company Size"...
-
Tidewave Bio appoints Prof. Alexander Eggermont as Head of Clinical Advisory Board to advance its biopsy-native immunotherapy for solid tumors.